The Biden-Harris administration is proposing to expand Medicare and Medicaid coverage for anti-obesity medications, potentially providing millions of Americans access to life-saving treatments, while President-elect Donald Trump’s appointment of Robert F. Kennedy Jr. to lead the Department of Health and Human Services has sparked widespread criticism.